Aviva Systems Biology office will be closed for Thanksgiving - November 23rd, 2017 and November 24th, 2017.
Please go here for more info.

Now Offering Over 102,157 Antibodies & 44,722 Antigens!

PKA C-alpha/PKA C-beta Antibody - N-terminal region (OAAB16744)

Scroll Horizontally to view all Images
Print Page
  • Let us Help: Ask a Question
400ul
$320.00
In Stock
Gene Symbol:
PRKACA
NCBI Gene Id:
5566
Protein Name:
cAMP-dependent protein kinase catalytic subunit alpha
Swissprot Id:
P17612
Protein Accession #:
NP_002721.1
Alias Symbols:
PRKACA, PKACA, cAMP-dependent protein kinase catalytic subunit alpha
Replacement Item:
This antibody may replace item sc-111700 from Santa Cruz Biotechnology.
Description of Target:
Purified Rabbit Polyclonal Antibody (Pab)
Molecular Weight:
40590 Da
Host:
Rabbit
Clonality:
Polyclonal
Application:
WB, IHC
Tissue Tool:
Find tissues and cell lines supported by DNA array analysis to express PRKACA.
RNA Seq:
Find tissues and cell lines supported by RNA-seq analysis to express PRKACA.
Species Reactivity:
Human, Mouse
Predicted Homology Based on Immunogen Sequence:
Human; Mouse
Product Format:
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Reconstitution and Storage:
Maintain refrigerated at 2-8C for up to 6 months. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles.
Concentration:
Approximately 0.5mg/ml. Actual concentration varies with each lot.
Datasheets / Downloads:
OAAB16744
Sample Type Confirmation:

PRKACA is supported by BioGPS gene expression data to be expressed in Jurkat

Specificity:
This PKA C-alpha/PKA C-beta antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 16~46 amino acids from the N-terminal region of human PKA/C.
Isotype:
Ig
Application Info:
WB 1:100 - 500
IHC 1:50 - 100
Additional Information:
Precautions: PKA C-alpha/PKA C-beta Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.
:::
Function: Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis. Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA, TRPC1 and VASP. RORA is activated by phosphorylation. Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts. Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B- alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP. Prevents the antiproliferative and anti-invasive effects of alpha- difluoromethylornithine in breast cancer cells when activated RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+). TRPC1 activation by phosphorylation promotes Ca(2+) influx, essential for the increase in permeability induced by thrombin in confluent endothelial monolayers. PSMC5/RPT6 activation by phosphorylation stimulates proteasome. Regulates negatively tight junction (TJs) in ovarian cancer cells via CLDN3 phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding. Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis Isoform 2 phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation. Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation. May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT)
:::
Cellular Location: Cytoplasm. Cell membrane. Nucleus (By similarity). Mitochondrion (By similarity). Note=Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. Distributed throughout the cytoplasm in meiotically incompetent oocytes. Associated to mitochondrion as meiotic competence is acquired. Aggregates around the germinal vesicles (GV) at the immature GV s
Tissue Location: Isoform 1 is ubiquitous. Isoform 2 is sperm specific
Protocol:
Tips Information:

Product Protocol: PRKACA antibody tested with mouse Jurkat, mouse Heart by western blot (OAAB16744)

Please find the protocol used to generate the western blot data for item (OAAB16744) by going here

Product datasheet link: PRKACA antibody (OAAB16744)

The anti-PKA/C alpha/beta Pab (Cat. # OAAB16744) is used in Western blot to detect PKA/C alpha in Jurkat cell lysate (lane 1) and mouse heart tissue lysate (lane 2) .

Questions pertaining to this data can be directed to techsupport@avivasysbio.com

Aviva Systems Biology's PRKACA antibody (OAAB16744) has been tested using other cell lysates and tissues. To obtain more data about this antibody, please email us at info@avivasysbio.com

To order by phone call us at (888) 880-0001, fax us at (858) 552-6975 or send an email to info@avivasysbio.com. Aviva manufactures this antibody so we can offer the best price. Please contact us to request pricing information.

All of Aviva's products are guaranteed for the applications and experimental sample types mentioned. Are you curious if this product will work for you? Please contact us at techsupport@avivasysbio.com

Product Protocol: PRKACA antibody tested with human cancer, breast carcinoma, hepatocarcinoma in immunohistochemistry (IHC) (OAAB16744)

Please go here to see the protocol used for Aviva's PRKACA antibody (OAAB16744)

Product datasheet can be found here: PRKACA antibody (OAAB16744)

IHC information:
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Questions pertaining to this data can be directed to techsupport@avivasysbio.com

Aviva Systems Biology's PRKACA antibody (OAAB16744) has been tested using other cell lysates and tissues. To obtain more data about this antibody, please email us at info@avivasysbio.com

To order by phone call us at (888) 880-0001, fax us at (858) 552-6975 or send an email to info@avivasysbio.com. Aviva manufactures this antibody so we can offer the best price. Please contact us to request pricing information.

All of Aviva's products are guaranteed for the applications and experimental sample types mentioned. Are you curious if this product will work for you? Please contact us at techsupport@avivasysbio.com

 
X
Ask a Question

Tell us what you think about this item!

Write A Review
    Please, wait...